DE60103247D1 - Verfahren zur Herstellung von Formulierungen zur Direkttablettierung - Google Patents

Verfahren zur Herstellung von Formulierungen zur Direkttablettierung

Info

Publication number
DE60103247D1
DE60103247D1 DE60103247T DE60103247T DE60103247D1 DE 60103247 D1 DE60103247 D1 DE 60103247D1 DE 60103247 T DE60103247 T DE 60103247T DE 60103247 T DE60103247 T DE 60103247T DE 60103247 D1 DE60103247 D1 DE 60103247D1
Authority
DE
Germany
Prior art keywords
weight
formulations
preparation
excipient
direct tableting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60103247T
Other languages
English (en)
Other versions
DE60103247T2 (de
Inventor
Ta-Shuong Yeh
Daniel Hungting Yeh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEI MING PHARMACEUTICAL Manufacturing CO
Original Assignee
WEI MING PHARMACEUTICAL Manufacturing CO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WEI MING PHARMACEUTICAL Manufacturing CO filed Critical WEI MING PHARMACEUTICAL Manufacturing CO
Publication of DE60103247D1 publication Critical patent/DE60103247D1/de
Application granted granted Critical
Publication of DE60103247T2 publication Critical patent/DE60103247T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60103247T 2001-05-01 2001-09-04 Verfahren zur Herstellung von Formulierungen zur Direkttablettierung Expired - Lifetime DE60103247T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US847017 2001-05-01
US09/847,017 US6761905B2 (en) 2001-05-01 2001-05-01 Process for the preparation of direct tabletting formulations and aids

Publications (2)

Publication Number Publication Date
DE60103247D1 true DE60103247D1 (de) 2004-06-17
DE60103247T2 DE60103247T2 (de) 2005-05-04

Family

ID=25299560

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103247T Expired - Lifetime DE60103247T2 (de) 2001-05-01 2001-09-04 Verfahren zur Herstellung von Formulierungen zur Direkttablettierung

Country Status (11)

Country Link
US (1) US6761905B2 (de)
EP (1) EP1256338B1 (de)
CN (1) CN1309375C (de)
AT (1) ATE266388T1 (de)
DE (1) DE60103247T2 (de)
DK (1) DK1256338T3 (de)
ES (1) ES2220640T3 (de)
HK (1) HK1050147A1 (de)
PT (1) PT1256338E (de)
TR (1) TR200401489T4 (de)
TW (1) TWI284541B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040221631A1 (en) * 2002-09-05 2004-11-11 Kerrigan Kurt J. Composition for fertilizer tablet
BRPI0612802A2 (pt) * 2005-07-07 2010-11-30 Farnam Co Inc composições farmacêuticas de liberação sustentada para medicamentos extremamente hidrossolúveis
US8951562B2 (en) * 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
JP5612462B2 (ja) 2007-04-13 2014-10-22 ダウ グローバル テクノロジーズ エルエルシー 剤形用の粒状物質
NZ584521A (en) * 2007-10-10 2011-03-31 Avantor Performance Mat Inc Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
SG171362A1 (en) * 2008-11-20 2011-07-28 Avantor Performance Mat Inc Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
CN105878242A (zh) * 2009-04-01 2016-08-24 巴尔-波特拉及康邦亚股份有限公司 包括硝基儿茶酚衍生物的药物制剂及其制备方法
US10543166B2 (en) 2009-06-26 2020-01-28 Taris Biomedical Llc Implantable drug delivery devices and methods of making the same
WO2011057925A1 (en) 2009-11-11 2011-05-19 Borealis Ag A cable and production process thereof
ES2601884T3 (es) * 2010-03-19 2017-02-16 Daiichi Sankyo Company, Limited Procedimiento para mejorar la capacidad de disolución de un anticoagulante
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN111374953A (zh) * 2018-12-31 2020-07-07 上海鼎雅药物化学科技有限公司 对乙酰氨基酚片及其制备工艺
GB2595203A (en) 2020-03-03 2021-11-24 Alkaloid Ad Skopje Formulation
CN112076166A (zh) * 2020-09-21 2020-12-15 湖州展望药业有限公司 一种直压淀粉及其生产方法
CN114522147B (zh) * 2020-11-23 2023-08-04 武汉武药科技有限公司 卡谷氨酸固体制剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
DE3447422A1 (de) * 1984-12-24 1986-06-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von ascorbinsaeure-granulat
DE3505433A1 (de) 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
US4757090A (en) * 1986-07-14 1988-07-12 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
ES2039226T3 (es) 1986-12-30 1993-09-16 American Cyanamid Company Procedimiento para preparar composiciones que contienen policarbofil.
US5200193A (en) 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US4968509A (en) 1987-07-27 1990-11-06 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
ES2066092T3 (es) * 1990-11-29 1995-03-01 Wei Ming Pharmaceutical Mfg Co Coadyuvante para la formacion directa de comprimidos.
WO1993009763A1 (en) 1991-11-15 1993-05-27 Isp Investments Inc. Pharmaceutical tablet with pvp having an enhanced drug dissolution rate
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
US6083430A (en) * 1994-10-28 2000-07-04 Fuisz Technologies Ltd. Method of preparing a dosage unit by direct tableting and product therefrom
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
DE19628617A1 (de) 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6350751B1 (en) * 1999-10-11 2002-02-26 Pfizer Inc. Therapeutic agents

Also Published As

Publication number Publication date
DK1256338T3 (da) 2004-09-06
DE60103247T2 (de) 2005-05-04
EP1256338A2 (de) 2002-11-13
US6761905B2 (en) 2004-07-13
CN1309375C (zh) 2007-04-11
TR200401489T4 (tr) 2004-07-21
ATE266388T1 (de) 2004-05-15
ES2220640T3 (es) 2004-12-16
US20030017198A1 (en) 2003-01-23
PT1256338E (pt) 2004-09-30
CN1383813A (zh) 2002-12-11
EP1256338B1 (de) 2004-05-12
TWI284541B (en) 2007-08-01
EP1256338A3 (de) 2003-01-29
HK1050147A1 (en) 2003-06-13

Similar Documents

Publication Publication Date Title
DE60103247D1 (de) Verfahren zur Herstellung von Formulierungen zur Direkttablettierung
DK0655917T3 (da) Krystallinske amifostin-præparater og fremgangsmåder til fremstilling og anvendelse af samme
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
KR20010020592A (ko) 파로세틴 고형물 분산액을 제조하기 위한 새로운 방법
DK1262198T3 (da) Sammensætning med forhalet frigivelse af levodopa og carbidopa
NO20060149L (no) Farmasoytiske forbindelser av atorvastatin
ES2196803T3 (es) Procedimiento en fase acuosa para fabricar dispersiones solidas de paroxetina.
NO178914C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat for behandling av Diabetes mellitus
EP1243272A3 (de) Kristalline Amifostinzusammensetzungen und Verfahren für ihre Herstellung und ihre Verwendung
DK0575930T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske retardformer
ES2187457T3 (es) Procedimiento para la obtencion de formas de dosificacion solidas que contienen ciclodextrina.
HUP0103202A2 (hu) Nimeszulidot tartalmazó topikális gyógyászati készítmények és eljárás az előállításukra
ATE230979T1 (de) Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung
FR2819720B1 (fr) Nouveaux comprimes de fenofibrate
BR0008739A (pt) Composições de liberação controlada debeta-histina
UA27954C2 (uk) Біологічно активна речовина фармацевтичної композиції для лікування гіперглікемій та фармацевтична композиція з протигіперглікемічною активністю
NO900342L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-5,6-dihydrobenz(c)akridin-7-karboxylsyrer og beslektede forbindelser.
WO2006081320A3 (en) Pharmaceutical formulation
DE60013147D1 (en) Caspase-hemmer
DE60113807D1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans
ATE294580T1 (de) Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat
ATE374027T1 (de) Eine kondensierte indolverbindung enthaltendes arzneimittel
NZ532449A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and Crohn's disease
DK0420042T3 (da) Faste lægemiddelformer med højt verapamilindhold
DE60115450D1 (de) Pirlindolhydrochlorid-Matrixformulierungen mit verlängerter Wirkstofffreigabe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition